|
PDE6D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.219800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.887500E-02 |
| Normal-vs-Stage2 |
3.595700E-02 |
| Normal-vs-Stage3 |
3.620600E-03 |
| Normal-vs-Stage4 |
1.545600E-01 |
| Stage1-vs-Stage2 |
6.975000E-01 |
| Stage1-vs-Stage3 |
5.975600E-02 |
| Stage1-vs-Stage4 |
4.425600E-01 |
| Stage2-vs-Stage3 |
3.142000E-01 |
| Stage2-vs-Stage4 |
3.835200E-01 |
| Stage3-vs-Stage4 |
4.200100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.807670E-02 |
| Normal-vs-AfricanAmerican |
2.711600E-01 |
| Normal-vs-Asian |
5.217000E-01 |
| Caucasian-vs-AfricanAmerican |
3.097400E-01 |
| Caucasian-vs-Asian |
7.781800E-01 |
| AfricanAmerican-vs-Asian |
8.561000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.540900E-03 |
| Normal-vs-Female |
1.457630E-01 |
| Male-vs-Female |
1.054410E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.093980E-01 |
| Normal-vs-Age(41-60Yrs) |
2.482200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.207800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.352800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.351800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.003200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.251400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.291000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.215000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.877600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.106600E-01 |
| Normal-vs-Grade 2 |
3.093700E-02 |
| Normal-vs-Grade 3 |
1.668180E-02 |
| Normal-vs-Grade 4 |
3.818400E-02 |
| Grade 1-vs-Grade 2 |
2.420200E-01 |
| Grade 1-vs-Grade 3 |
2.061800E-01 |
| Grade 1-vs-Grade 4 |
2.203400E-01 |
| Grade 2-vs-Grade 3 |
5.247600E-01 |
| Grade 2-vs-Grade 4 |
7.462400E-01 |
| Grade 3-vs-Grade 4 |
9.554200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.186200E-02 |
| Normal-vs-ccB subtype |
4.141400E-03 |
| ccA subtype-vs-ccB subtype |
1.605510E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.360460E-02 |
| Normal-vs-N1 |
2.389000E-01 |
| N0-vs-N1 |
9.952000E-01 |
|
|
